Document Detail

Multiple episodes of ischemic preconditioning are not associated with loss of benefit: preliminary clinical experience.
MedLine Citation:
PMID:  16341299     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: As a clinical analogue of ischemic preconditioning (IP), preinfarction angina (PA) shares a well-documented protective effect in the setting of acute myocardial infarction (AMI) by reducing infarct size, preserving left ventricular function and improving prognosis. In the experimental setting, multiple cycles of IP may induce the loss of this protection. OBJECTIVE: To evaluate the effect of repeated cycles of PA on clinical outcomes in patients exhibiting a first AMI. METHODS: Seventy-four consecutive patients with AMI, in whom PA was the surrogate of experimental IP, were studied prospectively. All patients had poor or no collaterals. The patients were divided into three groups: group 1 (n=32) comprised patients without PA (control subjects); groups 2 (n=24) and 3 (n=18) comprised patients reporting one to four and more than four episodes of new-onset PA, respectively (preconditioned groups). Both of the preconditioned groups were compared with the control subjects with regard to creatine kinase-MB release, corrected Q-T interval (QTc) at discharge and major in-hospital complications. RESULTS: Compared with the control subjects, groups 2 and 3 exhibited reduced creatine kinase-MB release (75+/-26 IU/L and 85+/-22 IU/L versus 172+/-13 IU/L, P=0.004 and P=0.024, respectively), lower discharge QTc values (418+/-15 ms and 422+/-19 ms versus 443+/-38 ms, P=0.004 and P=0.031, respectively), and a reduced incidence of postinfarction angina (25% and 11% versus 44%, P<0.05), arrhythmias (0% and 0% versus 22%, P<0.05) and pulmonary edema (4% and 0% versus 28%, P<0.05). CONCLUSIONS: Regardless of the number of recurrences, IP seems to be a powerful intervention to reduce infarct size, limit QTc at discharge and improve the outcome in patients with AMI.
Christodoulos E Papadopoulos; Haralampos I Karvounis; Georgios E Parharidis; Georgios E Louridas
Related Documents :
10894579 - Safety and efficacy of digital rectal examination in patients with acute myocardial inf...
2913729 - Comparison of mortality and myocardial infarction rates in stable angina pectoris with ...
2975949 - Lack of effect of warfarin on the restenosis rate or on clinical outcome after balloon ...
2902779 - The efficacy of the addition of nifedipine in patients with mixed angina compared to pa...
2621769 - Silent myocardial ischemia during holter monitoring in ischemic heart disease.
10924299 - Cardiovascular risk and therapeutic benefit of coronary interventions for patients with...
7720439 - Severe clostridium difficile colitis.
95279 - Pitfalls in measuring r waves in pacemaker-dependent patients.
9541479 - Type 1 gaucher disease: phenotypic expression and natural history in japanese patients.
Publication Detail:
Type:  Evaluation Studies; Journal Article    
Journal Detail:
Title:  The Canadian journal of cardiology     Volume:  21     ISSN:  0828-282X     ISO Abbreviation:  Can J Cardiol     Publication Date:  2005 Dec 
Date Detail:
Created Date:  2005-12-12     Completed Date:  2006-02-24     Revised Date:  2008-04-09    
Medline Journal Info:
Nlm Unique ID:  8510280     Medline TA:  Can J Cardiol     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  1291-5     Citation Subset:  IM    
First Cardiology Department, AHEPA University Hospital, Aristotle University of Thessaloniki, Greece.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Acute Disease
Angina, Unstable* / drug therapy
Case-Control Studies
Creatine Kinase / blood
Ischemic Preconditioning, Myocardial*
Middle Aged
Myocardial Infarction / diagnosis,  prevention & control*
Prospective Studies
Treatment Outcome*
Reg. No./Substance:
EC Kinase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The incidence and prognosis of Brugada electrocardiographic pattern in the Manitoba Follow-Up Study.
Next Document:  Economic implications of treatment guidelines for congestive heart failure.